Tetratherix Limited (ASX:TTX)

Market Cap	210.68M
Revenue (ttm)	2.00M +157.2%
Net Income	-11.97M
EPS	-0.31
Shares Out	50.77M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,449
Average Volume	18,719
Open	4.150
Previous Close	4.150
Day's Range	4.050 - 4.150
52-Week Range	2.880 - 5.800
Beta	n/a
RSI	45.80
Earnings Date	May 22, 2026

About Tetratherix

Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical device in the areas of bone regeneration, tissue spacing, and tissue healing applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Employees: 15
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: TTX

Financial Performance

In fiscal year 2025, Tetratherix's revenue was 1.05 million, an increase of 21.88% compared to the previous year's 863,651. Losses were -9.43 million, 269.1% more than in 2024.